Mapfre

EARNINGS IN REVERSE?

23/09/21 -" Faurecia (Buy, France) is probably the first to spill the beans: H2 sales guidance and EBIT margin downgraded, lower base for 2022 on continued disruptions of the semiconductors crisis for the Autos ..."

PDF page sample
Pages
55
Language
English
Published on
23/09/21
Download
You may also be interested by these reports :
13/05/24
We’ve integrated the financial results for the FY23 and Q1 24, highlighting a pronounced adverse impact from weather conditions for Sampo, albeit ...
13/05/24
Like most European peers, Swiss Life reported its 2023 figures under the new IFRS accounting rules 17 and 9 for the first time with a new income ...
08/05/24
• Insurance revenues were up by 5.5% to €15.1bn for the Q1 24 • Net profit attributable to shareholders rose by 68% to €2.1bn for Q1 24 • RoE was ...
06/05/24
Baloise’s 2023 results were disappointing despite the profit warning in November 2023. The net profit of CHF240m was below the consensus and our ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO